Poller L, Taberner D A, Thomson J M, Darby K V
United Kingdom Reference Laboratory for Anticoagulant Reagents and Control, Withington Hospital, Manchester.
J Clin Pathol. 1988 Apr;41(4):361-4. doi: 10.1136/jcp.41.4.361.
National External Quality Assessment Scheme surveys on the prothrombin time test carried out in hospitals in the United Kingdom have been performed at regular intervals since 1972. Performance has been assessed by comparing observed variability between hospitals with that predicted by a statistical model. The model was based on results from 53 survey plasmas issued between 1980 and 1987. These showed a linear correlation between logarithms of mean and standard deviation of reported ratios. Precision improved until the human brain thromboplastin, Manchester Comparative Reagent, was withdrawn in January 1986. There then followed a pronounced overall deterioration which, by October 1987, had not corrected to the levels achieved by 1985. When the recent results from 1986-87 were analysed according to Quick test reagent only one reagent (ISI 1.1) showed an improvement in precision. Performance of the other Quick test reagents, all with higher ISI values, had not regained the standards of precision previously achieved by the human brain reagent.
自1972年以来,英国定期开展针对医院凝血酶原时间检测的国家外部质量评估计划调查。通过将各医院观察到的变异性与统计模型预测的变异性进行比较来评估检测性能。该模型基于1980年至1987年间发放的53份调查血浆的结果。这些结果显示报告比值的均值对数与标准差对数之间存在线性相关性。在1986年1月人脑凝血活酶(曼彻斯特比较试剂)停用之前,检测精密度一直在提高。随后出现了明显的整体恶化,到1987年10月,仍未恢复到1985年所达到的水平。当仅根据Quick检测试剂分析1986 - 1987年的最新结果时,只有一种试剂(国际敏感指数为1.1)的精密度有所提高。其他国际敏感指数值更高的Quick检测试剂,其精密度尚未恢复到先前人脑试剂所达到的标准。